journal article·2016-11-22

Cancer Cell Membrane–Biomimetic Nanoparticles for Homologous-Targeting Dual-Modal Imaging and Photothermal Therapy

Ze Chen, Pengfei Zhao, Zhenyu Luo, Mingbin Zheng, Hao Tian, Ping Gong, Guanhui Gao, Hong Pan, Lanlan Liu, Aiqing Ma, Haodong Cui, Yifan Ma, Lintao Cai

ACS Nano· Volume 10· Issue 11
Publisher page

Abstract

An active cell membrane-camouflaged nanoparticle, owning to membrane antigens and membrane structure, can achieve special properties such as specific recognition, long blood circulation, and immune escaping. Herein, we reported a cancer cell membrane-cloaked nanoparticle system as a theranostic nanoplatform. The biomimetic nanoparticles (indocyanine green (ICG)-loaded and cancer cell membrane-coated nanoparticles, ICNPs) exhibit a core-shell nanostructure consisting of an ICG-polymeric core and cancer cell membrane shell. ICNPs demonstrated specific homologous targeting to cancer cells with good monodispersity, preferable photothermal response, and excellent fluorescence/photoacoustic (FL/PA) imaging properties. Benefited from the functionalization of the homologous binding adhesion molecules from cancer cell membranes, ICNPs significantly promoted cell endocytosis and homologous-targeting tumor accumulation in vivo. Moreover, ICNPs were also good at disguising as cells to decrease interception by the liver and kidney. Through near-infrared (NIR)-FL/PA dual-modal imaging, ICNPs could realize real-time monitored in vivo dynamic distribution with high spatial resolution and deep penetration. Under NIR laser irradiation, ICNPs exhibited highly efficient photothermal therapy to eradicate xenografted tumor. The robust ICNPs with homologous properties of cancer cell membranes can serve as a bionic nanoplatform for cancer-targeted imaging and phototherapy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Advanced Nanomaterials in Catalysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Guangdong Key Laboratory of Nanomedicine, CAS Key Lab for Health Informatics, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, People’s Republic of China

University of Chinese Academy of Sciences, Beijing 100049, People’s Republic of China

Guangdong Key Laboratory for Research and Development of Natural Drugs, Guangdong Medical University, Dongguan 523808, People’s Republic of China

Funding

Ministry of Science and Technology of the People's Republic of China · China Postdoctoral Science Foundation · National Natural Science Foundation of China · Chinese Academy of Sciences · Dongguan Municipality · Shenzhen Municipality

References (40)

Show source-provided references
1. 10.1021/ar200023x10.1021/ar200023x ↗
2. 10.2217/nnm.13.810.2217/nnm.13.8 ↗
3. 10.1021/ar200019c10.1021/ar200019c ↗
4. 10.1016/j.nano.2014.01.00910.1016/j.nano.2014.01.009 ↗
5. 10.1002/anie.20090267210.1002/anie.200902672 ↗
6. 10.1038/nprot.2012.08210.1038/nprot.2012.082 ↗
7. 10.1038/nature1521810.1038/nature15218 ↗
8. 10.1038/nnano.2013.5410.1038/nnano.2013.54 ↗
9. 10.1038/nprot.2006.35910.1038/nprot.2006.359 ↗
10. 10.1039/C5NR02470F10.1039/C5NR02470F ↗
11. 10.1021/acsnano.5b0213210.1021/acsnano.5b02132 ↗
12. 10.1038/nnano.2013.25410.1038/nnano.2013.254 ↗
13. 10.1002/adma.20150608610.1002/adma.201506086 ↗
14. 10.1038/nnano.2012.21210.1038/nnano.2012.212 ↗
15. 10.1002/adma.20150332310.1002/adma.201503323 ↗
16. 10.1021/acsami.6b0085310.1021/acsami.6b00853 ↗
17. 10.1002/adfm.20150105010.1002/adfm.201501050 ↗
18. 10.1021/nl504798g10.1021/nl504798g ↗
19. 10.1073/pnas.110663410810.1073/pnas.1106634108 ↗
20. 10.1038/nrd259110.1038/nrd2591 ↗
21. 10.1083/jcb.20091010410.1083/jcb.200910104 ↗
22. 10.1021/nn400334y10.1021/nn400334y ↗
23. Iurisci I. · Anticancer Res. · 2009 · 29 · 403
24. 10.1158/0008-5472.CAN-04-075410.1158/0008-5472.CAN-04-0754 ↗
25. 10.1016/j.biomaterials.2010.03.03510.1016/j.biomaterials.2010.03.035 ↗
26. 10.1021/nl500618u10.1021/nl500618u ↗
27. 10.1021/acsnano.5b0132610.1021/acsnano.5b01326 ↗
28. 10.1021/ja809086q10.1021/ja809086q ↗
29. 10.1016/j.jphotobiol.2004.01.00210.1016/j.jphotobiol.2004.01.002 ↗
30. 10.1021/mp200526m10.1021/mp200526m ↗
31. 10.1083/jcb.148.4.77910.1083/jcb.148.4.779 ↗
32. Glinsky V. V. · Cancer Res. · 2003 · 63 · 3805
33. 10.1074/jbc.M20959020010.1074/jbc.M209590200 ↗
34. 10.1016/j.biomaterials.2014.04.01910.1016/j.biomaterials.2014.04.019 ↗
35. 10.1021/nn506238610.1021/nn5062386 ↗
36. 10.1038/nrc158610.1038/nrc1586 ↗
37. 10.1146/annurev.immunol.25.022106.14160910.1146/annurev.immunol.25.022106.141609 ↗
38. 10.1126/science.122956810.1126/science.1229568 ↗
39. 10.1016/j.ijpharm.2005.11.00310.1016/j.ijpharm.2005.11.003 ↗
40. 10.1021/mp800270t10.1021/mp800270t ↗